A machine learning (ML) approach for identifying genetic biomarkers and new molecular targets associated with impaired survival of breast cancer patients

BACKGROUND Machine learning (ML) tools are suitable to dive vast amounts of clinical and genetic information in order to identify genetic biomarkers of worse survival and potential new molecular targets. This study has investigated the ability of one such tool to identify genetic biomarkers associated with higher risk of mortality in breast cancer, biomarkers that…